Eriksen, D. O. (2026). Correction to “ HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression”EriksenDO, KrogL, OstenfeldEB, et al. HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression. Acta Obstet Gynecol Scand. 2026;105(2): 377–385. doi:10.1111/aogs.70128. Wiley. https://doi.org/10.1111/aogs.70199
Chicago-Zitierstil (17. Ausg.)Eriksen, Dina Overgaard. Correction to “ HPV Vaccination Following Cervical Intraepithelial Neoplasia Grade 2 Diagnosis and Risk of Progression”EriksenDO, KrogL, OstenfeldEB, Et al. HPV Vaccination Following Cervical Intraepithelial Neoplasia Grade 2 Diagnosis and Risk of Progression. Acta Obstet Gynecol Scand. 2026;105(2): 377–385. Doi:10.1111/aogs.70128. Wiley, 2026. https://doi.org/10.1111/aogs.70199.
MLA-Zitierstil (9. Ausg.)Eriksen, Dina Overgaard. Correction to “ HPV Vaccination Following Cervical Intraepithelial Neoplasia Grade 2 Diagnosis and Risk of Progression”EriksenDO, KrogL, OstenfeldEB, Et al. HPV Vaccination Following Cervical Intraepithelial Neoplasia Grade 2 Diagnosis and Risk of Progression. Acta Obstet Gynecol Scand. 2026;105(2): 377–385. Doi:10.1111/aogs.70128. Wiley, 2026. https://doi.org/10.1111/aogs.70199.